Inflows Detected in Schwab U.S. Large-Cap Growth ETF: $161.4M Increase in Outstanding Units

The Schwab U.S. Large-Cap Growth ETF (SCHG) has seen a $161.4 million inflow, a 0.4% increase in outstanding units. Among the largest components, Elevance Health Inc (ELV) is down 0.8%, Zoetis Inc (ZTS) is up 0.8%, and Apollo Global Management Inc (APO) is up 0.3%. The ETF's 52-week range is $21.37 to $29.49.

The Schwab U.S. Large-Cap Growth ETF (SCHG) has experienced a notable inflow of $161.4 million, representing a 0.4% increase in outstanding units over the past week [1]. This growth is driven by increased investor interest in large-cap growth stocks, particularly those with significant exposure to technology and artificial intelligence (AI).

Among the largest components of SCHG, Elevance Health Inc (ELV) saw a decline of 0.8%, while Zoetis Inc (ZTS) and Apollo Global Management Inc (APO) both increased by 0.8% and 0.3%, respectively [1]. The 52-week price range for SCHG is between $21.37 and $29.49, with the current share price hovering around $29.38 [1].

Looking at the financial performance of Elevance Health, analysts forecast a quarterly earnings report of $9.20 per share, representing a year-over-year decline of 9.1% [2]. Revenue is expected to increase by 11.4% to $48.13 billion, while various revenue components such as 'Revenues- Premiums' and 'Revenues- Service fees' are forecasted to change by 11.9% and -1.8%, respectively [2].

The inflow into SCHG can be attributed to its focus on large-cap growth, particularly in the technology sector. Analysts and investors are optimistic about the long-term prospects of these companies, despite recent market volatility. The ETF's high concentration in tech stocks, including the 'Magnificent 7,' makes it a strong play for investors seeking exposure to AI and tech growth [3].

In summary, the significant inflow into SCHG highlights investor confidence in large-cap growth stocks, particularly those with strong AI and tech exposure. While individual components like ELV have seen fluctuations in performance, the overall trend remains positive for the ETF.

References:

[1] https://www.theonlineinvestor.com/article/202507/schg-elv-zts-apo-large-inflows-detected-at-etf-schg-elv-zts-apo-SCHG07142025.htm/
[2] https://finance.yahoo.com/news/elevance-health-elv-q2-earnings-131505596.html
[3] https://stockanalysis.com/etf/schg/